US FDA Reassures ALS Patients In Final Development Guidance

 
• By Derrick Gingery
  
nerve cells, concept for neurodegenerative and neurological disease
The FDA encouraged development of endpoints that measure function in daily living in final ALS drug development guidance. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet